- Home
- HOWL vs VGI Comparison
HOWL vs VGI Comparison
Compare HOWL & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- VGI
- Stock Information
- Founded
- HOWL 2017
- VGI 2012
- Country
- HOWL United States
- VGI United States
- Employees
- HOWL N/A
- VGI N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- VGI Investment Managers
- Sector
- HOWL Health Care
- VGI Finance
- Exchange
- HOWL Nasdaq
- VGI Nasdaq
- Market Cap
- HOWL 53.4M
- VGI N/A
- IPO Year
- HOWL 2021
- VGI N/A
- Fundamental
- Price
- HOWL $1.08
- VGI $7.89
- Analyst Decision
- HOWL Strong Buy
- VGI
- Analyst Count
- HOWL 3
- VGI 0
- Target Price
- HOWL $8.33
- VGI N/A
- AVG Volume (30 Days)
- HOWL 543.3K
- VGI 46.0K
- Earning Date
- HOWL 08-07-2025
- VGI 01-01-0001
- Dividend Yield
- HOWL N/A
- VGI 12.66%
- EPS Growth
- HOWL N/A
- VGI N/A
- EPS
- HOWL N/A
- VGI N/A
- Revenue
- HOWL $1,143,000.00
- VGI N/A
- Revenue This Year
- HOWL N/A
- VGI N/A
- Revenue Next Year
- HOWL N/A
- VGI N/A
- P/E Ratio
- HOWL N/A
- VGI N/A
- Revenue Growth
- HOWL N/A
- VGI N/A
- 52 Week Low
- HOWL $0.60
- VGI $6.68
- 52 Week High
- HOWL $4.18
- VGI $7.99
- Technical
- Relative Strength Index (RSI)
- HOWL 45.30
- VGI 63.10
- Support Level
- HOWL $1.03
- VGI $7.82
- Resistance Level
- HOWL $1.11
- VGI $7.97
- Average True Range (ATR)
- HOWL 0.07
- VGI 0.07
- MACD
- HOWL -0.02
- VGI 0.01
- Stochastic Oscillator
- HOWL 22.81
- VGI 82.98
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.